Published in J Cardiovasc Med (Hagerstown) on January 01, 2009
Advances in molecular imaging with ultrasound. Mol Imaging (2010) 1.42
Contrast-enhanced ultrasound for evaluation of high-intensity focused ultrasound treatment of benign uterine diseases: retrospective analysis of contrast safety. Medicine (Baltimore) (2015) 0.82
Validation of contrast-enhanced ultrasound-derived intensity-time gradients in submandibular gland sialolithotomy patients. Eur Arch Otorhinolaryngol (2012) 0.77
Ultrasonographic findings in Crohn's disease. J Ultrasound (2014) 0.75
Toxic agents in a toxic research environment? The case of contrast ultrasound. J Cardiovasc Med (Hagerstown) (2009) 0.75
Application of ultrasound microbubble contrast technology in ophthalmic targeted therapy: literature analysis. Int J Ophthalmol (2011) 0.75
Identification of surgically-induced longitudinal lesions of the equine deep digital flexor tendon in the digital flexor tendon sheath using contrast-enhanced ultrasonography: an ex-vivo pilot study. Acta Vet Scand (2014) 0.75
SICUS and CEUS imaging in Crohn's disease: an update. J Ultrasound (2017) 0.75
Update on Magnetic Resonance Imaging and Ultrasound Evaluation of Crohn's Disease. Gastroenterol Hepatol (N Y) (2016) 0.75
ST-segment elevation associated with allergic reaction to echocardiographic contrast agent administration. Neth Heart J (2014) 0.75
A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J (2011) 3.14
Diagnostic accuracy and clinical utility of noninvasive testing for coronary artery disease. Ann Intern Med (2010) 2.80
Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release (2006) 2.41
Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation (2009) 2.01
Congenital aortic stenosis in adults: rate of progression and predictors of clinical outcome. Int J Cardiol (2007) 1.97
The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr (2007) 1.95
Efficient quantification of the left ventricular volume using 3-dimensional echocardiography: the minimal number of equiangular long-axis images for accurate quantification of the left ventricular volume. J Am Soc Echocardiogr (2007) 1.93
Sustained improvement after combined anterior mitral leaflet extension and myectomy in hypertrophic obstructive cardiomyopathy. Circulation (2003) 1.89
Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers. Eur Heart J (2009) 1.73
Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. Eur Heart J (2007) 1.72
Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc Imaging (2009) 1.70
Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets. Circulation (2005) 1.69
Factors affecting sensitivity and specificity of diagnostic testing: dobutamine stress echocardiography. J Am Soc Echocardiogr (2009) 1.67
Usefulness of contrast echocardiography for diagnosis of left ventricular noncompaction. Am J Cardiol (2005) 1.66
Validation of a new score for the assessment of mitral stenosis using real-time three-dimensional echocardiography. J Am Soc Echocardiogr (2009) 1.59
Non-compaction cardiomyopathy is associated with mitral annulus enlargement and functional impairment: a real-time three-dimensional echocardiographic study. J Heart Valve Dis (2008) 1.56
Paradoxical contributions of non-compacted and compacted segments to global left ventricular dysfunction in isolated left ventricular noncompaction. Am J Cardiol (2006) 1.55
Changes in mitral regurgitation after transcatheter aortic valve implantation. Catheter Cardiovasc Interv (2010) 1.54
Stable angina pectoris: head-to-head comparison of prognostic value of cardiac CT and exercise testing. Radiology (2011) 1.46
Clinical outcome following Transcatheter Aortic Valve Implantation in patients with impaired left ventricular systolic function. Catheter Cardiovasc Interv (2012) 1.45
Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Circ Res (2013) 1.44
Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution. Circ Heart Fail (2010) 1.44
Aortic valve replacement for aortic stenosis is associated with improved aortic distensibility at long-term follow-up. Am Heart J (2007) 1.44
Quantification of left ventricular systolic dyssynchrony by real-time three-dimensional echocardiography. J Am Soc Echocardiogr (2008) 1.44
Reduced regional systolic function is not confined to the noncompacted segments in noncompaction cardiomyopathy. Int J Cardiol (2008) 1.42
The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet (2010) 1.41
Physical training-induced weight reduction is associated with improved aortic distensibility. Angiology (2009) 1.40
Computed tomography coronary imaging as a gatekeeper for invasive coronary angiography in patients with newly diagnosed heart failure of unknown aetiology. Eur J Heart Fail (2013) 1.39
Toxoplasma gondii serostatus is not associated with impaired long-term survival after heart transplantation. Transplantation (2013) 1.39
Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function. Circ Heart Fail (2011) 1.20
Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol (2004) 1.19
Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation (2005) 1.18
Accuracy and reproducibility of quantitation of left ventricular function by real-time three-dimensional echocardiography versus cardiac magnetic resonance. Am J Cardiol (2008) 1.17
Incidence, pathophysiology, and treatment of complications during dobutamine-atropine stress echocardiography. Circulation (2010) 1.16
Feasibility and reproducibility of left ventricular rotation parameters measured by speckle tracking echocardiography. Eur J Echocardiogr (2009) 1.15
Age-related changes in the biomechanics of left ventricular twist measured by speckle tracking echocardiography. Am J Physiol Heart Circ Physiol (2008) 1.14
Importance of transducer position in the assessment of apical rotation by speckle tracking echocardiography. J Am Soc Echocardiogr (2008) 1.12
A comparison between QLAB and TomTec full volume reconstruction for real time three-dimensional echocardiographic quantification of left ventricular volumes. Echocardiography (2007) 1.07
Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol (2007) 1.07
Noninvasive imaging of the vulnerable atherosclerotic plaque. Curr Probl Cardiol (2010) 1.07
Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging (2010) 1.07
Patient-reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice. Circ Heart Fail (2011) 1.07
Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts. BMJ (2012) 1.06
Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients. Transplantation (2007) 1.06
Assessment of left atrial volume and function by real-time three-dimensional echocardiography. Int J Cardiol (2007) 1.04
Cardiac involvement in adults with m.3243A>G MELAS gene mutation. Am J Cardiol (2006) 1.02
Quantification of left ventricular volumes and function in patients with cardiomyopathies by real-time three-dimensional echocardiography: a head-to-head comparison between two different semiautomated endocardial border detection algorithms. J Am Soc Echocardiogr (2007) 1.01
High-speed photography during ultrasound illustrates potential therapeutic applications of microbubbles. Med Phys (2005) 1.00
Assessment of left atrial ejection force in hypertrophic cardiomyopathy using real-time three-dimensional echocardiography. J Am Soc Echocardiogr (2007) 1.00
Left ventricular solid body rotation in non-compaction cardiomyopathy: a potential new objective and quantitative functional diagnostic criterion? Eur J Heart Fail (2008) 0.98
Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient. JIMD Rep (2011) 0.98
Contrast superharmonic imaging: a feasibility study. Ultrasound Med Biol (2003) 0.98
The mild form of mucopolysaccharidosis type I (Scheie syndrome) is associated with increased ascending aortic stiffness. Heart Vessels (2008) 0.98